Chromatography + mass spectrometry pure-play. Absorbing BD Biosciences (~$17.5B) — scale compounding. Application-specific columns create recurring consumable lock-in.
Research snapshot · Not reviewed
WATWaters
Chromatography, mass spectrometry, software
Open WAT in Robinhood ↗Conviction●○○○○1 of 5
Research target—Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap37.24BSnapshot value
BD Biosciences integration ($17.5B acquisition); precision medicine driving instrument demand; consumable pull-through from growing installed base.
Integration execution risk (BD Biosciences); instrument cycle lumpiness; competitive pressure from Thermo/Agilent/Shimadzu.
needs X/Reddit sentiment sweep
Snapshot · Not reviewed🟢 Confirmed · ins+$0.5M(2buy👥) · 13F 21+/4- · short↑0.25
Snapshot · Not reviewed